CARGO Therapeutics Files 10-Q for Q1 2025
| Field | Detail |
|---|---|
| Company | Cargo Therapeutics, Inc. |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, financials
Related Tickers: CRGX
TL;DR
CRGX 10-Q filed. Financials and biz updates for Q1 2025 out.
AI Summary
CARGO Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial operations and business activities, including references to agreements like the Amendment to Oxford Agreement and the Stanford License. The company's business address is 835 Industrial Road, Suite 400, San Carlos, CA 94070.
Why It Matters
This 10-Q filing provides investors and stakeholders with an update on CARGO Therapeutics' financial health and operational progress for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a biotechnology company, CARGO Therapeutics is subject to inherent risks associated with drug development, regulatory approvals, and market competition.
Key Players & Entities
- CARGO Therapeutics, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of reporting period
- 835 Industrial Road, Suite 400, San Carlos, CA 94070 (location) — Company's business address
- Amendment to Oxford Agreement (contract) — Mentioned agreement
- Stanford License (contract) — Mentioned agreement
FAQ
What is the primary business of CARGO Therapeutics, Inc.?
CARGO Therapeutics, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its SIC code [2836].
When was the 10-Q filing submitted?
The 10-Q filing was submitted on May 8, 2025.
What is the fiscal year end for CARGO Therapeutics, Inc.?
The fiscal year end for CARGO Therapeutics, Inc. is December 31.
What specific agreements are mentioned in the filing context?
The filing context mentions the 'Amendment to Oxford Agreement' and the 'Stanford License'.
What is the company's SEC file number?
The SEC file number for CARGO Therapeutics, Inc. is 001-41859.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding CARGO Therapeutics, Inc..